Danaher & Respironics

This morning, Respironics (RESP) reported earnings of 36 cents a share which was inline with Wall Street’s expectations:

Fiscal second-quarter net income was $24.1 million, or 33 cents per share, compared with $20.1 million, or 28 cents, a year ago. Net income for the current quarter included stock compensation expenses representing about 3 cents per diluted share after taxes.
Excluding items, the company reported a profit of 36 cents per share, matching the average analyst estimate, according to Reuters Estimates.
Net sales totaled $257.9 million, up 14 percent. Foreign currency exchange rates reduced revenue by about by 1 percent during the quarter.
Domestic revenue increased 15 percent to $176.9 million.
For fiscal-year 2006, Respironics forecast earnings per share, excluding equity compensation expense, in the range of $1.46 to $1.48. Earnings per share estimates for the quarter ending March 31, are expected to be 40 cents to 41 cents, excluding items.

Danaher (DHR) earned 81 cents a share, which beat estimates by one penny a share:

Industrial tool maker Danaher Corp. on Thursday said fourth-quarter profit rose 20 percent, helped by stronger demand for professional instruments used in environmental science and medicine.
Earnings increased to $261.6 million, or 81 cents per share, from $217.7 million, or 67 cents per share, a year earlier.
Analysts on average expected profit of 80 cents per share, according to Reuters Estimates.
Sales also topped forecasts, rising 14 percent to $2.26 billion. Revenue rose 24 percent in Danaher’s professional instrumentation division, its biggest, to $1.17 billion.
Chief Executive Lawrence Culp said in a statement that he was confident the company would be able to deliver “excellent results in 2006,” but did not issue a specific earnings forecast.

Also, Chipotle’s (CMG) IPO price was raised for the second time. The stock will now go public at $22, or 38 times earnings.

Posted by on January 26th, 2006 at 9:38 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.